Sciton ProFractional-XC
Er:YAG Resurfacing · Er:YAG 2940nm fractional with coagulation
Sciton ProFractional-XC pricing is not published by the manufacturer, and we have not yet verified a US market range. Sciton ProFractional-XC holds FDA 510(k) clearance for its marketed indication. Figures are market estimates verified August 6, 2026.
What it's actually cleared for: 2940nm Er:YAG fractional ablative resurfacing (JOULE/Profile family)
Last verified: August 6, 2026 · How we verify
New: —|Used: —market estimate, no email required
| Manufacturer | Sciton |
|---|---|
| Company | Owner: Employee-owned (co-founders James Hobart and Daniel Negus) (family / founder owned, since 1997) · Distribution: direct |
| Category | Resurfacing, Tattoo & Vascular |
| Technology | Er:YAG 2940nm fractional with coagulation |
| FDA status | FDA Cleared |
| New price range | Not published |
| Used price range | Not published |
| Consumables | Not published |
| Launch year | 2008 |
| Last verified | August 6, 2026 |
Overview
Fractional erbium module on Joule
FDA & regulatory status
What it's actually cleared for:
2940nm Er:YAG fractional ablative resurfacing (JOULE/Profile family)
510(k) numbers
K101916
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Treatment economics
Economics data for this platform hasn't been published yet.
Chains using this device
No confirmed chain deployments recorded yet.
Owner reviews
Write a reviewNo verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.
Alternatives
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first full census of the US aesthetic device market — preview it free.